FDA Drug recall D-0024-2025
AK Forte Ortiga y Omega 3 Cont
- FDA Drug
- Class II
- ongoing
- Published 2024-10-30
On 2024-10-30 the FDA classified a Class II recall of AK Forte Ortiga y Omega 3 Cont by C And A Naturistics, citing marketed without an Approved NDA/ANDA: FDA analysis found the product to be tainted with undeclared diclofenac and acetaminophen.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0024-2025 |
| Classification | Class II |
| Status | ongoing |
| Initiated | 2024-10-08 |
| Published | 2024-10-30 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | C And A Naturistics |
| Distribution | US |
Product
AK Forte Ortiga y Omega 3 Cont. Neto 100 Tabletas, 400 mg,
Reason
Marketed without an Approved NDA/ANDA: FDA analysis found the product to be tainted with undeclared diclofenac and acetaminophen.
Identifiers
| code_info | All Lots |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: ongoing.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0024-2025%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.